National Health Investors Inc. (NHI) Reaches New 1-Year High at $77.80
National Health Investors Inc. (NYSE:NHI) shares reached a new 52-week high during mid-day trading on Friday . The stock traded as high as $77.80 and last traded at $77.80, with a volume of 62,821 shares. The stock had previously closed at $77.08.
Several research analysts recently issued reports on the stock. JMP Securities reissued a “hold” rating on shares of National Health Investors in a report on Saturday, June 4th. Zacks Investment Research cut shares of National Health Investors from a “buy” rating to a “hold” rating in a report on Thursday, May 12th. Cantor Fitzgerald assumed coverage on shares of National Health Investors in a report on Thursday, June 23rd. They set a “hold” rating and a $70.00 price target for the company. Finally, BMO Capital Markets increased their price target on shares of National Health Investors from $65.00 to $69.00 and gave the stock an “outperform” rating in a report on Wednesday, March 30th. Five equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. National Health Investors presently has a consensus rating of “Hold” and an average target price of $68.67.
The stock’s 50-day moving average price is $73.90 and its 200 day moving average price is $66.89. The company has a market capitalization of $2.98 billion and a P/E ratio of 19.35.
National Health Investors (NYSE:NHI) last announced its quarterly earnings data on Friday, May 6th. The real estate investment trust reported $1.16 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $1.17 by $0.01. The business had revenue of $59.02 million for the quarter, compared to the consensus estimate of $57.81 million. During the same period in the prior year, the company posted $1.13 earnings per share. National Health Investors’s quarterly revenue was up 5.0% compared to the same quarter last year. Equities analysts anticipate that National Health Investors Inc. will post $4.87 EPS for the current year.
The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, August 10th. Shareholders of record on Thursday, June 30th will be issued a dividend of $0.90 per share. This represents a $3.60 annualized dividend and a yield of 4.64%. The ex-dividend date is Tuesday, June 28th.
In other National Health Investors news, EVP Kevin Carlton Pascoe sold 2,000 shares of the firm’s stock in a transaction on Tuesday, May 10th. The shares were sold at an average price of $70.72, for a total transaction of $141,440.00. Following the completion of the transaction, the executive vice president now directly owns 19,241 shares of the company’s stock, valued at approximately $1,360,723.52. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Robert A. Mccabe, Jr. sold 1,250 shares of the firm’s stock in a transaction on Monday, June 13th. The stock was sold at an average price of $71.61, for a total transaction of $89,512.50. Following the transaction, the director now directly owns 9,736 shares of the company’s stock, valued at $697,194.96. The disclosure for this sale can be found here.
Several hedge funds and institutional investors have bought and sold shares of NHI. Westfield Capital Management Co. LP raised its position in National Health Investors by 81.4% in the fourth quarter. Westfield Capital Management Co. LP now owns 436,425 shares of the real estate investment trust’s stock valued at $26,565,000 after buying an additional 195,807 shares during the period. Advantus Capital Management Inc raised its position in National Health Investors by 3.7% in the fourth quarter. Advantus Capital Management Inc now owns 50,606 shares of the real estate investment trust’s stock valued at $3,080,000 after buying an additional 1,800 shares during the period. Schroder Investment Management Group acquired a new position in National Health Investors during the fourth quarter valued at approximately $4,973,000. Vanguard Group Inc. raised its position in National Health Investors by 7.0% in the fourth quarter. Vanguard Group Inc. now owns 5,098,352 shares of the real estate investment trust’s stock valued at $310,337,000 after buying an additional 335,445 shares during the period. Finally, New York State Common Retirement Fund raised its position in National Health Investors by 2.9% in the fourth quarter. New York State Common Retirement Fund now owns 35,300 shares of the real estate investment trust’s stock valued at $2,149,000 after buying an additional 1,000 shares during the period.
National Health Investors, Inc is a self-managed real estate investment trust (REIT) specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. The Company is engaged in the business of owning and financing healthcare properties.
Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.